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This paper has two primary aims: to present the data on the
prevalence of licit and illicit substance use among the general
population in the Republic of Croatia and to compare these
prevalence rates with those from other European countries. The
data on the prevalence in Croatia were gathered by empirical
research on a nationally representative sample of Croatian
adults aged 15-64 years (N = 4756). The data on the
prevalence of licit drugs for other European countries were
obtained through secondary analysis of raw data from the
Special Eurobarometer 385 (tobacco) and 331 (alcohol), and
the source of data on illicit drugs was the EMCDDA's Statistical
Bulletin 2012. The results showed that, in Croatia, last month
prevalence of smoking was 37.4%, which is among the highest
in Europe and above the European average (32.4%). In the
month prior to the research, 60.8% of adults in Croatia drank
alcohol, which is among the lower prevalence rates compared
to the other European countries and also lower than the
European average (70.3%). Cannabis was the most widely
used illicit drug in Croatia, 15.6% of adults used it at least once
in their lifetime, which is below the European average (23.7%).
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The use of both licit (tobacco, alcohol) and illicit substances has
been known to mankind since ancient times. In the past their
use was present in the regions of their origin, but today the
use of licit and illicit substances is widely spread all around
the world, especially in the Western society (United Nations
Office on Drugs and Crime, 2010). It represents one of the ma-
jor public health problems throughout the world, with far-rea-
ching consequences for individuals, families and general wel-
fare of countries worldwide (Sakoman, 2006). Experience has
shown that it is not easy to combat the production and distri-
bution of both licit and illicit substances – which are linked to
dependency on these substances – nor to prevent other seri-
ous individual and social damage (van der Stel & Voordewind,
1998). Although it is known that the use of licit substances is
also potentially very harmful, the use of tobacco and alcohol
is socially accepted, even though smoking is becoming less
accepted (United Nations Office on Drugs and Crime, 2010).
The initial assessment of factors responsible for the global bur-
den of disease, tobacco, alcohol and illicit drugs together con-
tributed to 12.4% of the total number of deaths in the world
in the year 2000 (World Health Organization, 2002).
Globally, smoking is the leading cause of adverse health ef-
fects. According to the estimates of the World Health Organi-
zation, there are one billion and one hundred million smok-
ers around the world, or about one third of the world popu-
lation over the age of 15 years (World Health Organization,
2013a). The prevalence of current tobacco smoking is an im-
portant predictor of the future burden of tobacco-related dis-
eases (World Health Organization, 2012). The World Health
Organization estimates that in developed countries 41% of men
and 21% of women smoke, and in developing countries 48%
of men and 8% of women, noting that the number of young
people and women who smoke in many countries is increas-
ing (World Health Organization, 2002).
According to the estimates of the World Health Organi-
zation (2004), about 2 billion people worldwide consume al-
coholic beverages, and 76.3 million are dependent on alcohol.
The global burden associated with the consumption of alco-
holic beverages, in terms of morbidity and mortality, is signi-
ficant in almost all parts of the world (World Health Orga-
nization, 2002). The harmful use of alcohol is associated with
many serious health, social and developmental issues, includ-
ing violence, child abuse and neglect, and absenteeism in the
workplace, and also harms the well-being and health of peo-
ple around the drinker (World Health Organization, 2011).
According to data from the United Nations Office on Drugs
and Crime (2010), it is estimated that worldwide between 155558
and 250 million people have taken illicit drugs at least once in
the year 2008, which is between 3.5% and 5.7% of the popu-
lation aged 15-64 years, while between 18 and 38 million peo-
ple are addicted to illicit drugs. Drug addiction is closely asso-
ciated with the major social problems such as poverty, unem-
ployment, prostitution, delinquency, crime, homelessness,
etc. (United Nations International Drug Control Programme,
1995). Globally, cannabis users are the majority of users of illi-
cit drugs, among 129-190 million people, or between 2.9 and
4.3% of the population aged 15-64 years (United Nations Of-
fice on Drugs and Crime, 2010). Amphetamines are the second
most commonly used illicit drug, followed by cocaine and
opiates (United Nations Office on Drugs and Crime, 2010).
The problem of substance use is also a serious social
problem in Croatia, for both licit and illicit substances (Hibell
et al., 2012; Katalinić, Kuzman, Markelić, & Mayer, 2012; Office
for Combating Drugs Abuse of the Government of the Repu-
blic of Croatia, 2011; Orban & Glavak, 2006; Sakoman, 2008).
Consequently, Croatia has a history of institutional coping
with substance use and there has been a lot of effort to reduce
the harm resulting from substance use, for both individuals
and society. The efficiency of these attempts is mostly condi-
tioned by knowledge of the basic characteristics of the phe-
nomenon of substance use. Therefore, the insight into the pre-
valence of licit and illicit drug use among the general popula-
tion is of the utmost importance. The most important way to
assess the prevalence of substance use are studies among the
general population. However, due to the specifics of the prob-
lem itself, the estimates are often made based on the research
conducted among some specific target groups (school chil-
dren or vulnerable groups) or through some indirect meth-
ods. Still, an increasing number of countries recognize the im-
portance of conducting researches among the general popu-
lation, especially for the development of strategies to combat
drug abuse, and such researches are becoming essential in
the process of reaching elemental insight into the state of
drug use. In Europe, the agency responsible for collecting the
data on drug use and addiction is the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA). To ensure
factual, objective, reliable and comparable information on drugs
and drug addiction at the European level, EMCDDA has de-
veloped five specific epidemiological indicators, in collabora-
tion with the Reitox network, experts across Europe and with
other international organizations competent in the field of
drugs and drug addiction. The five key indicators are the ba-
sis for the EMCDDA reporting on trends and developments
in the European drug situation (European Monitoring Centre
for Drugs and Drug Addiction, 2012b). They are: General po-559
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pulation surveys, used to obtain information on drug use a-
mong the general population; Problem drug use, used to col-
lect data on the prevalence and incidence of problem drug
use at national and local level; Treatment demand indicator,
used to describe the population of problem drug users enter-
ing treatment; Drug-related deaths and mortality, used to ob-
tain statistics on the number and characteristics of people
who die as a consequence of drug use, and finally Drug-relat-
ed infectious diseases, used to collect data on drug-related
infectious diseases, particularly among injecting drug users.
Comprehensive understanding of the extent of the substance
abuse problem requires examination of all these indicators.
An analysis of the available official documents as well as
existing scientific research on substance (ab)use in the Repu-
blic of Croatia revealed that all the indicators except general
population survey have been relatively systematically collect-
ed (Office for Combating Drugs Abuse of the Government of
the Republic of Croatia, 2011; European Monitoring Centre
for Drugs and Drug Addiction, 2012a). Furthermore, analyses
have shown that there is a lack of information concerning the
problem of substance use on the extent and use patterns of
individual types of drugs amongst the general population.
However, some studies have been conducted which give an
insight into the problem of substance use in some specific po-
pulations, like youth. European School Survey Project on Al-
cohol and Other Drugs (ESPAD) is conducted in Croatia reg-
ularly since 1995, and provides snapshots of levels of licit and
illicit drug use, trends and attitudes of 15 to 16-year-old school
students across Europe (Hibell et al., 2012). Also, reports and
studies like the 2003 Croatian Health Survey (World Health
Organization, 2009), Global Status Report on Alcohol 2004
(World Health Organization, 2004), and databases like the
European Health for All Database (World Health Organization,
2013b) provide some insight into the extent of the problem of
tobacco and alcohol use in Croatia, but up to date there was
no scientific research on the prevalence of illicit drug use a-
mong the general population. Also, no research to date has
included the use of both licit and illicit substances among the
general population. Consequently, any effort to contextualize
the situation of substance use in Croatia by comparing it with
other European countries was not possible. Because of all the
aforementioned, it was crucial to conduct a general popula-
tion survey on substance use in Croatia, and the results pre-
sented in this paper were obtained by the first comprehen-
sive research about licit and illicit drugs use among the gen-
eral population in Croatia. This paper has two primary aims:
to present the data on the prevalence of licit and illicit sub-560
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stance use among the general population in the Republic of
Croatia and to compare these prevalence rates with those from
other European countries.
METHODS
The data on the prevalence of substance use among the gen-
eral population in Croatia was gathered by empirical research
described in detail in this chapter of the paper. The sources of
data on the prevalence of substance use among the general
population in different European countries were Eurobaro-
meter surveys conducted on behalf of the European Commis-
sion (licit drugs), and the EMCDDA's Statistical Bulletin (illic-
it drugs). More specifically, the estimations of prevalence of
licit drug use for European countries were based on secon-
dary analysis of data collected through the Special Eurobaro-
meter 385 (tobacco)1 and the Special Eurobarometer 331 (alco-
hol)2 (European Commission, 2012b, 2012c). Both datasets are
available at GESIS – The Data Archive for the Social Sciences.
Secondary analysis of these datasets enabled a cross-country
comparison of the prevalence of tobacco and alcohol use in spe-
cific age groups. The source of data on illicit drug use for Eu-
ropean countries presented in this paper was the EMCDDA's
Statistical Bulletin 2012, which contains the data from the most
recent national general population survey available since the
year 2000. These data were modified to meet the purpose of
this research, and are presented in the Results section in or-
der to facilitate the comparison of results obtained by the re-
search on illicit drug use among the general population in
Croatia with other European countries.
Sample
The target population in this study were residents of the Re-
public of Croatia aged between 15 and 64 years, living in pri-
vate households. The planned sample was divided into two
subsamples. In the sample of population aged 15-64 years, a
target of 4,000 interviews was set, and with oversampling, an
additional 800 respondents aged 15-34 years were included in
the research. The purpose of oversampling was to get a more
robust sample of this segment of population that is more prone
to consume all types of drugs. For the purpose of this study,
10,212 addresses were selected and 9,102 of them were valid.
From them, 4,831 respondents participated in the study, which
resulted in a 53.1% response rate, and 4,756 properly filled in
the questionnaires. Since minors (aged 15-17) were also inclu-
ded in the study, the Croatian Psychological Chamber's re-
commendations on including minors in the research were fol-
lowed and parental consent for interviewing a child was asked
for.561
The data was weighted to represent the distribution of
birth cohort and gender in the general population of Croatia.
The main characteristics of respondents after the process of
sample weighting are presented in Figure 1.
Furthermore, the 95% confidence intervals were used in
order to indicate precision of estimates of the population pre-
valence rates, and also to help identify gender and age differ-
ences in prevalence rates of licit and illicit substance use a-









For the purpose of this research, the Croatian translation of
the European Model Questionnaire (EMQ) was used, a question-
naire which is standardly used in national surveys on sub-
stance use, and which allows the international comparability
of the epidemiological status in the field of substance use
(European Monitoring Centre for Drugs and Drug Addiction,
2002). As this paper outlines the results on the prevalence of
licit drug use (tobacco, alcohol) and illicit drug use among the
general population, it is important to precisely define the terms
used. The term "prevalence" refers to the proportion of popu-
lation who reported taking substance over a particular time
period. The prevalence was measured in a way that respondents
were asked to recall their personal substance use in the following
periods: lifetime, last year and last month. Lifetime prevalence
refers to the proportion of the respondents in a sample who re-
ported ever using a particular substance. The respondent who
reported lifetime prevalence of use of the particular substance
may or may not be currently using that substance. Lifetime pre-
valence should not be interpreted in a way that a respondent
is seen as someone who used a substance for a longer time pe-
riod or will use it again in the future. Last year prevalence refers
to the proportion of the respondents in a sample who reported
using a particular substance in the year prior to the research.
Last year prevalence is often referred to as recent use of sub-
stance and it is an indicator of the situation in the field of sub-
stance use. Last month prevalence refers to the proportion of the
respondents in a sample who reported using a particular sub-
stance in the 30 days prior to the research. Last month preva-
lence is often referred to as current use of a particular sub-
stance. However, some of the respondents who reported current
substance use can be only occasional or first time users who
happen to have used a particular substance during the 30 days
prior to the research, and because of that current substance
use shouldn't be referred to as regular substance users (European
Monitoring Centre for Drugs and Drug Addiction, 2002).
Socio-demographic variables included gender and age of re-
spondents. The results are given for all respondents (aged be-
tween 15 and 64 years), hereinafter in the text referred to as
all adults, for young adults (aged between 15 and 34 years),
and are also presented by age categories (15-24 years, 25-34
years, 35-44 years, 45-54 years, and 55-64 years).
Procedure
The data were gathered by face-to-face interviews in the respon-
dents' households. The fieldwork was conducted from May to Au-
gust 2011. Since questions concerning substance use are seen
as very sensitive, much attention has been devoted to ensuring
the anonymity of respondents. The interviewers were asked to563
give the respondents introduction that solicits their participation
in the survey and to give them an invitation letter which ex-
plained the purpose of the study to reassure them that the study
was genuine, about confidentiality, importance of the research,
information how the results are going to be presented etc. The
respondents were assured that their participation in the research
was voluntary and anonymous, and that all collected information
was confidential, as well as that the collected data would be used
only as a summary data, and would not be processed as single
cases. Also, it was made possible, due to the sensitivity of the topic,
for the respondents to fill out the questionnaire on their own.
The interviewer assisted the respondent in clarifying any que-
stions they did not understand if such problems occurred. As
an additional reassurance of anonymity, respondents were given
an unmarked envelope and were instructed that upon finish-
ing with the questionnaire they had to insert the completed
survey in the envelope, seal it and mix it with other unmarked
envelopes of other respondents that the interviewer had alrea-
dy collected. The interviewing took approximately 20 minutes.
RESULTS
Tobacco use
As shown in Table 1, in Croatia more than half of all adults re-
ported having ever smoked tobacco in their lifetime (57.5%).
Prevalence:
lifetime last year last month
Tobacco use % CI- CI+ % CI- CI+ % CI- CI+
All adults (15-64) Total 57.5 55.5 59.5 39.7 37.9 41.6 37.4 35.7 39.3
Males 62.9 60.2 65.4 43.3 40.9 45.7 40.9 38.5 43.3
Females 52.3 49.8 54.8 36.2 33.9 38.5 34.0 31.8 36.3
Young adults (15-34) Total 54.8 51.9 57.7 42.4 39.6 45.2 39.1 36.4 41.9
Males 58.1 54.2 62.0 44.9 41.1 48.8 42.1 38.3 46.0
Females 51.3 47.6 55.0 39.8 36.4 43.3 36.0 32.7 39.5
Age categories 15-24 50.1 46.2 53.9 40.0 36.2 44.0 36.0 32.2 39.8
25-34 59.7 56.3 62.9 44.9 41.7 48.1 42.4 39.3 45.6
35-44 64.6 60.9 68.1 46.9 43.2 50.6 44.4 40.7 48.2
45-54 60.3 56.7 63.8 37.8 34.6 41.1 36.1 32.9 39.4
55-64 51.3 48.3 54.3 26.2 23.8 28.7 25.9 23.5 28.4
The lifetime prevalence rate of tobacco consumption among
young adults was also high (54.8%). In the year prior to the
research 39.7% of all adults and 42.4% of young adults report-
ed having smoked tobacco, and in the month prior to the
research 37.4% of all adults and 39.1% of young adults. The
lowest last year and the last month prevalence rates of tobac-
co consumption were reported in the 55-64 age group (26.2%
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Lifetime, last year and
last month prevalence
rates of tobacco use in
Croatia with the 95%
confidence intervals,
among all adults and
young adults by
gender, and by age
categories (%)
and 25.9%, respectively), and the lowest lifetime prevalence
rate was similar in the oldest and the youngest age group
(51.3% and 50.1%, respectively), while in other age groups the
prevalence rates of tobacco consumption were around 60% for
the last year, and around 40% for the last month. In all preva-
lence categories, the reported rate of tobacco consumption was
higher among males than females among both all adults and
young adults. However, comparisons of confidence intervals
of the reported smoking prevalence rates showed that these
intervals in all prevalence categories among all adults do not
overlap, and among young adults do overlap. Thus, we can
conclude that only differences among all adults in lifetime,
last year and last month prevalence of smoking between ma-
les and females are statistically significant (Table 1).
Source: Dataset from Special Eurobarometer 385 wave 77.1 (European Commission, 2012c)
Figure 2 presents the proportion of smokers in the month
prior to the research in the adult population (15-64 years) in
Croatia and European countries (data from 2012). As shown in
Figure 2, there are great variations in the proportion of the a-
dult population smoking tobacco in the month prior to the re-
search across different European countries, ranging from 13.4%
to 45.4%. The proportion of smokers was the lowest (less than565
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The comparison of the
proportion of the adult
population (15-64
years old) who smoked
tobacco in the month
prior to the research in
Croatia and European
countries (%)
15%) in Sweden, and the highest (above 40%) in Greece and Bul-
garia. According to the results of this research, Croatia had very
high last month prevalence of smoking among the adult po-
pulation (37.4%), higher than the average proportion of popu-
lation smoking tobacco in the month prior to the research in
European countries (32.4%).
Alcohol use
The majority of respondents in Croatia in all age and gender
categories reported having ever consumed alcohol in their life-
time (Table 2). The lifetime prevalence rate was 86.4% for all
adults and 88.3% for young adults. Furthermore, 71.8% of all
adults and 79.5% of young adults reported alcohol consump-
tion in the year prior to the research, and 60.8% of all adults
and 66.8% of young adults reported alcohol consumption in
the month prior to the research. There were no considerable
differences in the lifetime prevalence of alcohol consumption
between different age groups, since the range of reported life-
time prevalence was between 83.1% (55-64 age group) and
91.7% (25-34 age group). However, the difference was more
prominent for the last year and last month prevalence rates of
alcohol use, where respondents from the oldest age group re-
ported considerably lower prevalence rates (59.6% and 50.8%,
respectively) than respondents from the younger age groups.
Reported prevalence rates of alcohol consumption were sta-
tistically significantly higher amongst males than females in
all prevalence categories, among both adults and young adults
(Table 2).
Prevalence:
lifetime last year last month
Alcohol use % CI- CI+ % CI- CI+ % CI- CI+
All adults (15-64) Total 86.4 84.6 88.1 71.8 69.8 73.7 60.8 58.8 62.7
Males 92.5 90.8 94.0 81.1 78.9 83.1 74.3 71.9 76.6
Females 80.3 77.7 82.7 62.5 59.9 65.1 47.2 44.8 49.7
Young adults (15-34) Total 88.3 86.1 90.2 79.5 76.9 81.8 66.8 64.1 69.3
Males 91.0 88.4 93.1 85.1 82.0 87.7 77.2 73.9 80.2
Females 85.4 82.4 88.0 73.8 70.3 77.0 56.0 52.5 59.4
Age categories 15-24 84.9 81.4 87.9 77.6 73.7 81.0 64.5 60.5 68.3
25-34 91.7 89.6 93.4 81.5 78.6 84.1 69.2 65.9 72.2
35-44 87.5 84.4 90.0 71.8 68.1 75.2 59.3 55.3 63.2
45-54 84.4 81.4 87.1 66.7 63.2 70.0 58.6 55.0 62.1
55-64 83.1 80.0 85.8 59.6 56.0 63.0 50.8 47.3 54.3
Figure 3 presents the comparison of proportion of the a-
dult population (15-64 years) who used alcohol in the month
prior to the research in Croatia and European countries (data
from 2009).566
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Lifetime, last year and
last month prevalence
rates of alcohol use in
Croatia with the 95%
confidence intervals,
among all adults,
young adults, and by
age categories (%)
Source: Dataset from Special Eurobarometer 385 wave 72.3 (European
Commission, 2012b)
As shown in Figure 3, there are wide variations across
different countries in the proportion of adults (15-64 years
old) who used alcohol in the month prior to the research,
with national prevalence figures varying from 53.9% to 84%.
The proportion of adults who consumed alcohol in the last
month was the highest (above 80%) in Denmark and Sweden,
and the lowest (less than 60%) in Hungary, Portugal, and Ita-
ly. According to the results of the current research, in Croatia
60.8% of all adults drank alcohol in the month prior to the re-
search, which is among the lower prevalence rates compared
to the other European countries, and also lower than the ave-
rage proportion of adult population who used alcohol in the
last month in European countries (70.3%).
Illicit drug use
The lifetime prevalence rate of using any illicit drugs in Cro-
atia was 16.0% of all adults, and around one-quarter (25.7%)
of young adults (Table 3).567
 FIGURE 3
The comparison of the
proportion of the adult
population (15-64
years old) who used
alcohol in the month
prior to the research
in Croatia and Euro-
pean countries (%)
Prevalence:
lifetime last year last month
Any illicit drug use % CI- CI+ % CI- CI+ % CI- CI+
All adults (15-64) Total 16.0 14.4 17.8 5.3 4.5 6.4 3.2 2.5 3.9
Males 21.4 19.0 24.1 7.4 6.1 9.0 4.4 3.4 5.8
Females 10.7 9.2 12.3 3.3 2.6 4.2 1.9 1.4 2.5
Young adults (15-34) Total 25.7 23.0 28.7 10.7 8.9 12.9 6.2 4.9 7.9
Males 32.6 28.9 36.6 14.4 11.6 17.8 8.5 6.3 11.3
Females 18.6 15.8 21.8 6.9 5.4 8.9 3.9 2.9 5.3
Age categories 15-24 22.6 19.3 26.4 12.7 10.2 15.6 7.3 5.4 9.9
25-34 28.9 25.4 32.6 8.7 6.7 11.2 5.0 3.7 6.8
35-44 17.0 14.4 20.0 3.3 2.2 5.0 1.8 1.1 3.2
45-54 7.8 5.8 10.4 1.0 0.5 2.1 0.8 0.3 1.8
55-64 1.9 1.2 3.0 0.5 0.2 1.3 0.5 0.2 1.3
Note: The term "any illicit drugs" refers to taking one or more of the
following drugs: cannabis, amphetamines, ecstasy, cocaine, heroin,
and LSD.
5.4% of all adults and 10.8% of young adults reported ha-
ving used some type of illicit drug at least once in the year
prior to the research, and 3.2% of all adults and 6.2% of young
adults in the month prior to the research (Table 3). Analysis of
age differences showed higher lifetime prevalence rates of
taking any illicit drugs among those younger than 44 years
than among older age groups – the highest lifetime preva-
lence rate was reported in the 25-34 age group (28.9%), fol-
lowed by the 15-24 and 35-44 age groups (22.6% and 17%,
respectively). Furthermore, higher last year and last month pre-
valence rates of taking any illicit drugs were reported among
those younger than 34 years – both the highest last year and
last month prevalence rates were reported by the 15-24 age
group (12.7% and 7.3%, respectively). Statistically significantly
more males than females reported having used any illicit drugs
in all prevalence categories, among both adults and young
adults (Table 3).
Cannabis was the most commonly used illicit drug in Cro-
atia (Table 4). The lifetime prevalence rate was 15.6% for all
adults and 25.3% for young adults. Furthermore, 5% of all a-
dults and 10.5% of young adults reported cannabis use in the
year prior to the research, and 2.9% of all adults and 6.1% of
young adults reported cannabis consumption in the month
prior to the research. Higher lifetime prevalence rates of can-
nabis use were reported among those younger than 44 years
than among older age groups – the highest lifetime prevalence
rate was reported in the 25-34 age group (28.2%), followed by
the 15-24 and 35-44 age groups (22.5% and 16.7%, respective-568
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Lifetime prevalence,
last year and last
month prevalence
rates of any illicit drug




adults by gender, and
by age categories
ly). Higher last year and last month prevalence rates of can-
nabis use were reported among those younger than 34 years,
with the highest last year and last month prevalence rates
reported by the 15-24 age group (12.6% and 7.3%, respective-
ly). The reported lifetime, last year and last month prevalence
rates of cannabis use were statistically significantly higher
among males than females, among both adults and young a-
dults (Table 4).
Prevalence:
lifetime last year last month
Cannabis use % CI- CI+ % CI- CI+ % CI- CI+
All adults (15-64) Total 15.6 14.0 17.5 5.0 4.2 6.0 2.9 2.3 3.7
Males 20.9 18.4 23.6 7.1 5.8 8.7 4.2 3.2 5.5
Females 10.4 8.9 12.0 2.9 2.3 3.8 1.6 1.2 2.3
Young adults (15-34) Total 25.3 22.6 28.3 10.5 8.7 12.7 6.1 4.7 7.8
Males 32.0 28.3 36.0 14.3 11.5 17.7 8.4 6.2 11.2
Females 18.4 15.6 21.6 6.6 5.1 8.6 3.7 2.7 5.1
Age categories 15-24 22.5 19.1 26.2 12.6 10.1 15.6 7.3 5.4 9.9
25-34 28.2 24.8 31.9 8.4 6.5 10.9 4.8 3.5 6.6
35-44 16.7 14.2 19.6 2.5 1.7 3.9 1.5 0.8 2.6
45-54 7.2 5.3 9.7 0.7 0.3 1.6 0.5 0.2 1.3
55-64 1.6 1.0 2.6 0.5 0.2 1.2 0.5 0.2 1.2
Lifetime prevalence rates of use of illicit drugs other than
cannabis were considerably lower than prevalence rates of can-
nabis use among both all adults (below 3%): amphetamines
2.6%, ecstasy 2.5%, cocaine 2.3%, LSD 1.4%, and heroin 0.4%,
and young adults (below 6%): amphetamines 5.1%, ecstasy 4.6%,
cocaine 3.8%, LSD 2.4%, and heroin 0.5%. Last year preva-
lence rates for all illicit drugs other than cannabis were up to
0.8% among all adults and 1.6% among young adults, and last
month prevalence rates were up to 0.3% among all adults and
0.5% among young adults (Table 5). Although there were dif-
ferences between males and females and also between differ-
ent age categories for illicit drugs other than cannabis, be-
cause of the low prevalence rates of these illicit drugs, detailed
analysis on their use will not be performed.
Furthermore, since the use of all illicit drugs except can-
nabis had relatively low prevalence rates in Croatia (Table 5),
the comparison of data on illicit drug use from Croatia with
that from other European countries will be presented in de-
tail only for cannabis. In Figure 4 the comparison of lifetime,
last year and last month prevalence rates of cannabis use in
European countries (data from the most recent national gene-
ral population survey available since 2000) and Croatia, for all
adults and young adults are presented.569
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adults by gender, and
by age categories
All adults (15-64) Young adults (15-34) Age categories
Illicit drug use Total Males Females Total Males Females 15-24 25-34 35-44 45-54 55-64
Lifetime prevalence
Ecstasy 2.5 3.7 1.3 4.6 6.5 2.6 2.8 6.3 2.1 0.6 0.4
Amphetamines 2.6 3.6 1.6 5.1 6.5 3.6 3.7 6.6 1.5 0.6 0.4
Cocaine 2.3 3.2 1.4 3.8 5.1 2.5 2.5 5.1 2.7 0.5 0.5
Heroin 0.4 0.7 0.2 0.5 0.6 0.3 0.3 0.6 0.7 0.3 0.1
LSD 1.4 2.3 0.6 2.4 3.6 1.1 1.8 3.0 1.2 0.9 0.2
Last year prevalence
Ecstasy 0.4 0.6 0.1 0.5 0.7 0.2 0.6 0.3 0.4 0.3 0.2
Amphetamines 0.8 1.1 0.5 1.6 2.0 1.2 1.7 1.5 0.3 0.2 0.1
Cocaine 0.5 0.7 0.3 0.9 1.2 0.7 0.9 0.9 0.4 0.2 0.1
Heroin 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1
LSD 0.3 0.4 0.1 0.4 0.5 0.3 0.4 0.4 0.1 0.3 0.1
Last month prevalence
Ecstasy 0.2 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.3 0.3 0.1
Amphetamines 0.2 0.4 0.1 0.5 0.8 0.2 0.6 0.3 0.0 0.2 0.1
Cocaine 0.3 0.3 0.2 0.4 0.4 0.3 0.3 0.5 0.3 0.2 0.1
Heroin 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1
LSD 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.0
As seen in Figure 4, there were considerable differences
in prevalence rates of cannabis use among all adults between
European countries in all prevalence categories, with nation-
al prevalence figures varying from 1.6% to 32.5% for lifetime
use, 0.3% and 14.3% for last year use, and 0.1% and 7.6% for
last month use. Among the highest prevalence countries for
all prevalence categories of cannabis use among all adults
were Spain, Italy, and France, and the lowest Romania, Malta,
and Greece. The prevalence rate of lifetime cannabis use
among all adults in Croatia (15.6%) was lower than the aver-
age prevalence rate of cannabis use in the European countries
(23.7%), while last year and last month prevalence rates of
cannabis use in Croatia (5% and 2.9%, respectively) were sim-
ilar to the average prevalence rates of cannabis use in the Eu-
ropean countries (6.8% and 3.6%) (Figure 4).
As in Croatia, national prevalence rates of lifetime, last
year and last month cannabis use were higher among young
adults than among all adults in all European countries (Figure
4). Prevalence rates of cannabis use among young adults in
European countries varied from 3% to 49.3% for lifetime use,
0.6% and 20.7% for last year use, and 0.2% and 14.1% for last
month use. Among the highest prevalence countries for all
prevalence categories of cannabis use among young adults
were Czech Republic, France, Spain and Italy, and the lowest
Romania, Malta, and Greece. The prevalence rate of lifetime
cannabis use among young adults in Croatia (25.3%) was lo-
wer than the average prevalence rate of cannabis use in the Eu-
ropean countries (32.5%), whereas the last year and the last
month prevalence rates of cannabis use among young adults570
 TABLE 5
Lifetime prevalence,
last year and last
month prevalence
rates of use of illicit
drugs other than
cannabis in Croatia,
among all adults and
young adults by
gender, and by age
categories
in Croatia (10.5% and 6.1%, respectively) were similar to the
average prevalence rates of cannabis use in the European coun-
tries (12.4% and 6.6%).
Source: EMCDDA's Statistical Bulletin 2012 (European Monitoring
Centre for Drugs and Drug Addiction, 2012c).
In Table 6 the comparison of lifetime prevalence rates of
ecstasy, amphetamines, cocaine and LSD use in European
countries (data from most recent national general population
survey available since 2000) and Croatia are presented.
 FIGURE 4
The comparison of
lifetime, last year and
last month prevalence
rate of cannabis use
in Croatia and
European countries,
for all adults and
young adults (%)
Ecstasy Amphetamines Cocaine LSD
Lifetime preva-
lence in Croatia 2.5% 2.6% 2.3% 1.4%
European average 3.4% 3.8% 4.6% /
Range 0.4-8.3% 0.1-11.6% 0.3-10.2% 0.1-5.6%
Lowest-preva- Greece (0.4%) Greece (0.1%) Romania (0.3%) Romania (0.1%)
lence countries Romania (0.7%) Romania (0.1%) Lithuania (0.5%) Bulgaria (0.2%)
Norway (1.0%) Cyprus (0.7%) Greece (0.7%) Greece (0.3%)
Poland (1.2%) Portugal (0.9%) Poland (0.8%) Lithuania (0.4%)
Slovakia (1.2%) Malta (0.5%)
Highest-preva- United United Spain (10.2%) United
lence countries Kingdom (8.3%) Kingdom (11.6%) United Kingdom (5.6%)
Ireland (6.9%) Denmark (6.2%) Kingdom (8.9%) Czech Republic (2.6%)
Netherlands (6.2%) Sweden (5.0%) Italy (7.0%) Germany (2.4%)
Spain (4.9%) Ireland (4.5%) Ireland (6.8%)
Source: EMCDDA's Statistical Bulletin 2012 (European Monitoring Centre for
Drugs and Drug Addiction, 2012c).
For all listed illicit drugs4 there were considerable differ-
ences between countries in lifetime prevalence of use (Table 6).
Among the highest prevalence countries for lifetime preva-
lence rates of use of amphetamines, ecstasy, cocaine, and LSD
was the United Kingdom, and the lowest Greece and Roma-
nia. In Croatia, the lifetime prevalence of use of ampheta-
mines, ecstasy and cocaine among all adults (2.6%, 2.5%, and
2.3%, respectively) was somewhat lower than the European
average (3.8%, 3.4%, and 4.6%, respectively) (Table 6).
DISCUSSION
The results of this research showed that in Croatia around
one out of three adults (37.4%) aged 15-64 years smoked to-
bacco in the month prior to the research, which can be con-
sidered as current tobacco use (European Monitoring Centre
for Drugs and Drug Addiction, 2002). That is somewhat high-
er than the results of the previous study in Croatia based on
the Croatian Health Survey 2003 (according to Samardžić,
Santo, & Kožul, 2008), which showed that 31.4% of popula-
tion currently smoked tobacco. However, it should be noted
that in that study the respondents were older than 18 years,
and according to the results of this research, last month pre-
valence of smoking in the youngest age category (15-24 years)
was also high (33.3%), which might point to the increased
prevalence of smoking. Also, the results of ESPAD, research
which is continually conducted among young people (15-16
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valence of smoking among youth in Croatia was 41%, which
is very high (third in Europe after Latvia and Czech Repu-
blic), since the European average is 28% (Hibell et al., 2012). The
comparison of the proportion of smokers in the month prior
to the research obtained in this research with that from other
European countries showed that the proportion of smokers
in Croatia (37.4%) was among the highest in Europe and above
the European average, which was 32.4% (European Commis-
sion, 2012a).
According to the results of this research, in Croatia the
majority of all adults reported having used alcohol in their
lifetime (86.4%). That is higher than the results of previous
research in Croatia based on the Croatian Health Survey 2003
(according to World Health Organization, 2004), which showed
that lifetime prevalence of alcohol consumption was 77.1%.
The proportion of respondents who drank alcohol in the year
prior to the research in Croatia in the current research was
71.8%, and 60.8% of all adults in Croatia reported alcohol con-
sumption in the month prior to the research. That is lower
than the average proportion of adult population who used al-
cohol in the last month in the European countries (70.3%). How-
ever, it should be taken into account that results of the Special
Eurobarometer 331 (European Commission, 2010) showed that
at country level the European citizens most likely to have had
an alcoholic drink in the last 30 days (calculated from those
who claimed to have drunk alcohol in the past 12 months)
are, for example, Italians (94%) and Portuguese (91%), but at
the same time 39% of Italian and 42% of Portuguese respon-
dents reported that they have abstained from alcohol during
the past 12 months. For Croatia, the situation is similar – 28.2%
of all adults abstained from alcohol during the past 12 months,
but 83% of all respondents who reported having drunk alco-
hol in the past 12 months also reported having an alcoholic
drink in the last 30 days. This points to a polarity of con-
sumption patterns – while many do not consume alcoholic
beverages, those who do, tend to drink regularly (European
Commission, 2010). Also, last month prevalence is only a gene-
ral indicator of alcohol consumption, and to gain more insight
into alcohol consumption among the general population, the
frequency of drinking in the last 30 days should be analyzed,
and also the level of consumption (number of drinks drank
on one occasion).
The results of this research showed that, like in other Eu-
ropean countries, cannabis was the illicit drug most widely
used in Croatia. Among both all adults and young adults in
Croatia, prevalence rates of lifetime cannabis use were lower,
and last year and last month prevalence rates were similar to573
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the average prevalence rates of cannabis use in the European
countries. Other illicit drugs included in this study had lower
prevalence rates of use in both Croatia and other European
countries. For Croatia, lifetime prevalence of cannabis use in
ESPAD study was 18% which is very close to the European a-
verage (17%), and last month prevalence of cannabis use was
7% which is exactly like the European average (7%) (Hibell et
al., 2012). The results of this research also showed that the pre-
valence rate of last month cannabis use among young adults
in Croatia was very near the average of the European coun-
tries (6.1% vs. 6.6%), which leads to the conclusion that syste-
matic prevention should be especially aimed at young age
groups. Also, last month prevalence of cannabis use in Cro-
atia was highest among the 15-24 age group (7.3%), which
further supports this conclusion.
The results of this research indicated a significant rate of
consumption of both licit and ilicit substances in the Croatian
society. Since there are considerable differences in the preva-
lence rates of tobacco use, alcohol use, and cannabis use be-
tween men and women in Croatia, and there were also diffe-
rences among age categories, future research should take into
account gender and age variables in the comparison of data
from different countries. There are also other important vari-
ables that should be taken into account in analyzing the prob-
lem of both licit and illicit substance use, since they influence
their prevalence, but are beyond the scope of this paper, like
other socio-demographic variables (socio-economic status, edu-
cation, employment, marital status etc.). According to the re-
sults for the European Union, unemployed respondents were
the most likely of all socio-demographic groups to report they
currently smoke, also respondents with a lower socio-eco-
nomic status, and those with lower level of education (Euro-
pean Commission, 2012a). Furthermore, people who left edu-
cation earlier and people with lower financial status were less
likely to have had alcohol in the last year, while people with
higher occupational status were more likely to drink (European
Commission, 2010). Other socio-demographic variables should
also be taken into account when analyzing illicit substance
use, since they influence the prevalence of its use (European
Monitoring Centre for Drugs and Drug Addiction, 2012a; Uni-
ted Nations International Drug Control Programme, 1995). Also,
the comparisons of prevalence rates of substance use between
Croatia and other European countries presented in this paper
are basic comparisons, which serve as a frame for further
analyses. In order to have a complete picture of the extent of
substance use and allow comparisons between different coun-
tries, patterns of substance use, which can range from experi-
mental or occasional use to regular use and addiction, should
also be examined.574
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It should be taken into account that for illicit drugs, due
to the standardized methodology and the use of the Euro-
pean Model Questionnaire, the obtained data is highly com-
parable with data from other European countries. However,
there are still differences in the national survey sampling me-
thodology used and the year of data collection, response rate,
and population sizes, which means that small differences, in
particular between countries, should be interpreted with cau-
tion (European Monitoring Centre for Drugs and Drug Ad-
diction, 2012a). Other limitations of this study are the same as
in other studies on the substance use amongst the general
population. In this research, only individuals living in private
households were included, and because of that some groups
of respondents, for which a higher prevalence of substance
use might be expected, were not included (like individuals in
hospitals, prisons, therapeutic communities and correctional
facilities, homeless). Furthermore, in this research, self-report
measures of respondents' substance use were used, and al-
though measures were taken to ensure respondents' sinceri-
ty, giving socially desirable answers cannot be completely ex-
cluded. Despite the mentioned limitations, this study is very
important since it is the first of this type in the Republic of
Croatia. It was conducted on a large representative sample of
heterogeneous respondents and therefore it gives, on a na-
tional level, an overview of substance use amongst the gen-
eral population. This information is fundamental for under-
standing and assessing the situation in the field of substance
use, defining priorities and forming and evaluating strategies
for substance abuse prevention and drug policy, regulation
and control.
NOTES
1 The Special Eurobarometer 385 was part of the Eurobarometer wave
77.1 and was conducted in February and March 2012 on a multi-
stage, random sample. The target population in this study were res-
idents of the EU countries aged 15 years and over. The data were
gathered by face-to-face interviews and 26,751 respondents partici-
pated in the survey (about 1,000 interviews per country).
2 The Special Eurobarometer 331 was part of the Eurobarometer wave
72.3 and was conducted in October 2009 on a multi-stage, random
sample. The target population in this study were residents of the EU
countries aged 15 years and over. The data were gathered by face-to-
-face interviews and 26,788 respondents participated in the survey
(about 1,000 interviews per country).
3 The confidence intervals were used instead of a χ2 test to indicate
statistical significance of differences between estimations because χ2
test is sensitive to sample size. More precisely, the χ2 test tends to575
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produce lower p values when used on large samples, which could
lead to falsely rejecting a null hypothesis (Cohen, 1994; Higgins &
Green, 2008).
4 Data on heroin use among the general population in European coun-
tries, and the European average of lifetime prevalence of LSD use among
the general population were not available from the EMCDDA's
Statistical Bulletin.
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ovisnosti u općoj populaciji:
stanje u Hrvatskoj i usporedba
s drugim europskim zemljama
Renata GLAVAK TKALIĆ, Geran-Marko MILETIĆ
Institut društvenih znanosti Ivo Pilar, Zagreb
Slavko SAKOMAN
KBC "Sestre milosrdnice", Zagreb
Ovaj rad imao je dva cilja: podastrti podatke o prevalenciji
uporabe legalnih i ilegalnih sredstava ovisnosti u općoj
populaciji Republike Hrvatske i usporediti te prevalencije s
onima iz drugih europskih zemalja. Podaci o prevalencijama
u Hrvatskoj prikupljeni su empirijskim istraživanjem na
reprezentativnom uzorku odraslih između 15 i 64 godine
(N = 4756). Podaci o prevalencijama uporabe legalnih
sredstava ovisnosti dobiveni su sekundarnom analizom
sirovih podataka iz Specijalnog Eurobarometra 385 (duhan)
i 331 (alkohol), dok je izvor podataka o ilegalnim drogama
bio Statistički buletin Europskog centra za praćenje droga i
ovisnosti o drogama (EMCDDA) iz 2012. godine. Rezultati su
pokazali da je u Hrvatskoj prevalencija pušenja cigareta u
mjesecu koji je prethodio istraživanju bila 37,4%, što je
među najvišima u Europi i iznad je europskoga prosjeka
(32,4%). U mjesecu koji je prethodio istraživanju 60,8%
odraslih u Hrvatskoj pilo je alkohol, što je među nižim
prevalencijama u usporedbi s drugim europskim zemljama i
ispod je europskoga prosjeka (70,3%). Kanabis je najčešća
ilegalna droga u Hrvatskoj, 15,6% odraslih konzumiralo ga
je barem jednom u životu, što je ispod europskoga prosjeka
(23,7%).
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